By Kurt Orzeck ( March 1, 2013, 9:33 PM EST) -- Pharmaceutical company Depomed Inc. filed a patent infringement suit Thursday in Delaware federal court against Watson Laboratories Inc., saying the company's planned generic version of Depomed's extended-release metformin drug Glumetza for Type II diabetes violates four patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.